Twist Bioscience Q3 Results Top Estimates

RTTNews | il y a 876
Twist Bioscience Q3 Results Top Estimates

(RTTNews) - Genomics company Twist Bioscience Corp. (TWST) reported Friday a net loss attributable to common stockholders for the third quarter of $60.52 million or $1.08 per share, wider than $40.04 million or $0.82 per share in the prior-year quarter.

On average, seven analysts polled by Thomson Reuters expected the company to report a loss of $1.31 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter increased to $56.11 million from $35.02 million in the same quarter last year. Analysts expected revenues of $51.45 million for the quarter.

Looking ahead to fiscal 2022, the company now projects revenue of approximately $203 million, up from the prior guidance range of $191 million to $199 million.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
TSX Ends Modestly Lower

TSX Ends Modestly Lower

https://money.tmx.com/canadian-markets https://www.rttnews.com/3499633/bay-street-likely-to-open-slightly-higher.aspx?type=cn
RTTNews | il y a 23h 41min
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

The Switzerland market closed on a firm note on Friday, in line with markets across Europe, as investors picked up stocks from across several sectors. The benchmark SMI closed up 101.06 points or 0.88% at 11,589.34, slightly off the day's high of 11,597.29.
RTTNews | il y a 1
European Markets Close Higher

European Markets Close Higher

European stocks closed higher on Friday, as investors made some purchases at several counters as markets resumed trading after Christmas holidays. Activity was a bit subdued in most of the markets in the region amid a lack of triggers, and ahead of the New Year holidays coming up next week.
RTTNews | il y a 1